Literature DB >> 17505859

Margin and local recurrence after sublobar resection of non-small cell lung cancer.

Amgad El-Sherif1, Hiran C Fernando, Ricardo Santos, Brian Pettiford, James D Luketich, John M Close, Rodney J Landreneau.   

Abstract

BACKGROUND: Local recurrence is a major concern after sublobar resection (SR) of non-small cell lung cancer (NSCLC). We postulate that a large proportion of local recurrence is related to inadequate resection margins. This report analyzes local recurrence after SR of stage I NSCLC. Stratification based on distance of the tumor (<1 cm vs >or=1 cm) to the staple line was performed.
METHODS: We reviewed 81 NSCLC patients (44 female) who underwent operation over an 89-month period (January 1997 to June 2004). Mean forced expiratory volume in one second percentiles (FEV1) was 57%. Mean age was 70 (46-86) years. There were 55 wedge and 26 segmental resections. There were 41 tumors with a margin <1 cm and 40 with a margin >or=1 cm. Local recurrence was defined as recurrence within the ipsilateral lung or pulmonary hilum.
RESULTS: There were no perioperative deaths. Mean follow-up was 20 months. Margin distance significantly impacted local recurrence; 6 of 41 patients (14.6%) developed local recurrence in the group with margin less than 1 cm versus 3 of 40 patients (7.5%) in the group with margin equal to or more than 1 cm (P = .04). Of the 41 patients with margins <1 cm, segmentectomy was used in 7 (17%), whereas in the 40 patients with the >or=1 cm margins, segmentectomy was used in 19 (47.5%).
CONCLUSIONS: Margin is an important consideration after SR of NSCLC. Wedge resection is frequently associated with margins less than 1 cm and a high risk for locoregional recurrence. Segmentectomy appears to be a better choice of SR when this is chosen as therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17505859     DOI: 10.1245/s10434-007-9421-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  76 in total

1.  The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation.

Authors:  Yiyang Wang; Rui Wang; Difan Zheng; Baohui Han; Jie Zhang; Heng Zhao; Jizhuang Luo; Jiajie Zheng; Tianxiang Chen; Qingyuan Huang; Yihua Sun; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-14       Impact factor: 4.553

2.  Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.

Authors:  Hiran C Fernando; Rodney J Landreneau; Sumithra J Mandrekar; Francis C Nichols; Shauna L Hillman; Dwight E Heron; Bryan F Meyers; Thomas A DiPetrillo; David R Jones; Sandra L Starnes; Angelina D Tan; Benedict D T Daly; Joe B Putnam
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

3.  Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Authors:  Rodney J Landreneau; Daniel P Normolle; Neil A Christie; Omar Awais; Joseph J Wizorek; Ghulam Abbas; Arjun Pennathur; Manisha Shende; Benny Weksler; James D Luketich; Matthew J Schuchert
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

Review 4.  Latest update about virtual-assisted lung mapping in thoracic surgery.

Authors:  Kentaro Kitano; Masaaki Sato
Journal:  Ann Transl Med       Date:  2019-01

5.  Current trends in lung resection for T1a non-small cell lung cancer: is lobectomy still the answer?

Authors:  Syed S Razi; Despoina Daskalaki; Joshua Burack
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

6.  Tiny lung adenocarcinomas: better prognosis with a word of caution.

Authors:  Ramón Rami-Porta
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

7.  Locoregional recurrence after VATS surgery for NSCLC.

Authors:  Pierre-Emmanuel Falcoz; Gilbert Massard
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

8.  Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009.

Authors:  Anna L McGuire; Wilma M Hopman; Dimitri Petsikas; Ken Reid
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

Review 9.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 10.  Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more.

Authors:  Abby White; Scott J Swanson
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.